Table 1.

Circulating miRNAs in stroke baseline patients versus healthy controls.

	Discovery		Validation		Combined
miRNA	Log2FC 1	FDR 2	Log2FC 1	FDR 2	Log2FC 1	FDR 2
hsa-miR-451a	2.4	1.28 × 10−46	2.3	1.36 × 10−35	2.3	3.78 × 10−85
hsa-miR-574-5p	−2.2	5.17 × 10−21	−2.0	5.15 × 10−23	−2.1	7.25 × 10−53
hsa-miR-142-3p	−2.5	2.69 × 10−53	−2.1	1.54 × 10−42	−2.3	2.34 × 10−110
hsa-miR-6721-5p	−2.7	2.08 × 10−13	−2.2	4.17 × 10−11	−2.5	9.05 × 10−34
hsa-miR-4446-3p	−2.1	1.67 × 10−13	−2.2	3.09 × 10−13	−2.0	1.13 × 10−26
hsa-miR-485-3p	−2.9	1.71 × 10−17	−2.5	2.82 × 10−15	−2.4	1.33 × 10−30
hsa-miR-676-3p	−2.5	4.34 × 10−08	−2.5	8.88 × 10−08	−2.5	3.76 × 10−21
hsa-miR-379-5p	−2.7	4.76 × 10−26	−2.5	2.01 × 10−27	−2.5	1.67 × 10−50
hsa-miR-149-5p	−3.6	3.57 × 10−04	−2.9	7.29 × 10−04	−3.3	4.24 × 10−16
hsa-miR-411-5p	−3.1	8.11 × 10−18	−3.0	8.78 × 10−17	−3.0	1.11 × 10−40

¹ Log₂ fold change; ² false discovery rate.